Медицинская литература. Новинки

 

 

 

 

 

 

Клинические рекомендации Российской ассоциации эндокринологов по диагностике и лечению феохромоцитомы/параганглиомы

Вы можете загрузить полный текст статьи в формате pdf

В Клинических рекомендациях обсуждаются современные подходы к диагностике и лечению феохромоцитомы/параганглиомы.

Ключевые слова:
pheochromocytoma, paraganglioma, screening, plasma free metanephrines, urinary fractionated metanephrines, liquid chromatography, mass spectrometry, computed tomography, magnetic res-onance imaging, 123I-metaiodobenzylguanidine, 18F-fluorodeoxyglucose, феохромоцитома, параганглинома, скрининг, метанефрины, жидкостная хроматография, масс-спектрометрия, компьютерная томография, магнитно-резонансная

Литература:
1.1. DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and Genetics of Tumours of Endocrine Organs (IARC WHO Classification of Tumours). Lyon, France: World Health Organization; 2004.
2.2. Юкина М.Ю., Трошина Е.А., Бельцевич Д.Г., и др. Феохромоцитома/параганглиома: клинико-генетические аспекты. // Проблемы эндокринологии. - 2013. - Т. 59. - №3 - C. 19-26. doi: 10.14341/probl201359319-26.
3.3. Stolk RF, Bakx C, Mulder J, et al. Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines? J Clin Endocrinol Metab. 2013;98(3):1100-1106. doi: 10.1210/jc.2012-3669.
4.4. Бельцевич Д.Г., Трошина Е.А., Юкина М.Ю., и др. Инциденталома надпочечников. Диагностика и дифференциальная диагностика. Методические рекомендации для врачей первичного звена. / Под ред. Дедова И.И., Мельниченко Г.А. - М.; 2014.
5.5. Дедов И.И., Бельцевич Д.Г., Кузнецов Н.С., Мельниченко Г.А. Феохромоцитома. - М.: Практическая медицина; 2005.
6.6. Lenders JWM, Duh Q-Y, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915-1942. doi: 10.1210/jc.2014-1498.
7.7. Lenders JWM, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma. JAMA. 2002;287(11). doi: 10.1001/jama.287.11.1427.
8.8. Peitzsch M, Pelzel D, Glцckner S, et al. Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites. Clinica Chimica Acta. 2013;418:50-58. doi: 10.1016/j.cca.2012.12.031.
9.9. Mullins F, O’shea P, Fitzgerald R, et al. Enzyme-linked immunoassay for plasma-free metanephrines in the biochemical diagnosis of phaeochromocytoma in adults is not ideal. Clin Chem Lab Med. 2012;50(1). doi: 10.1515/cclm.2011.742.
10.10. Lenders JWM, Willemsen JJ, Eisenhofer G, et al. Is supine rest necessary before blood sampling for plasma metanephrines? Clin Chem. 2006;53(2):352-354. doi: 10.1373/clinchem.2006.076489.
11.11. Yu R, Wei M. False positive test results for pheochromocytoma from 2000 to 2008. Exp Clin Endocrinol Diabetes. 2010;118:577-585. doi: 10.1055/s-0029-1237699.
12.12. Neary NM, King KS, Pacak K. Drugs and pheochromocytoma - don’t be fooled by every elevated metanephrine. N Engl J Med.2011;364:2268-2270. doi: 10.1056/NEJMc1101502.
13.13. Algeciras-Schimnich A, Preissner CM, Young WF, et al. Plasma chromogranin a or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab. 2008;93(1):91-95. doi: 10.1210/jc.2007-1354.
14.14. De Jong WHA, Eisenhofer G, Post WJ, et al. Dietary influences on plasma and urinary metanephrines: Implications for diagnosis of catecholamine-producing tumors. J Clin Endocrinol Metab. 2009;94(8):2841-2849. doi: 10.1210/jc.2009-0303.
15.15. Gimenez-Roqueplo A-P, Caumont-Prim A, Houzard C, et al. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHX mutation carriers: A multicenter prospective study from the pgl.Eva investigators. J Clin Endocrinol Metab. 2013;98(1):E162-E173. doi: 10.1210/jc.2012-2975.
16.16. Luster M, Karges W, Zeich K, et al. Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-dopa pet/ct) for detecting pheochromocytoma. Eur J Nucl Med Mol Imaging. 2009;37(3):484-493. doi: 10.1007/s00259-009-1294-7.
17.17. Lev I, Kelekar G, Waxman A, et al. Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis. Endocr Pract. 2010;16(3):398-407. doi: 10.4158/ep09302.or.
18.18. Fonte JS, Robles JF, Chen CC, et al. False-negative 123I-MIBG spect is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease. Endocr Relat Cancer. 2011;19(1):83-93. doi: 10.1530/erc-11-0243.
19.19. Shulkin BL, Thompson NW, Shapiro B, et al. Pheochromocytomas: Imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET1. Radiology. 1999;212(1):35-41. doi: 10.1148/radiology.212.1.r99jl3035.
20.20. Timmers HJLM, Chen CC, Carrasquillo JA, et al. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-fdg) positron emission tomography. J Natl Cancer Inst. 2012;104(9):700-708. doi: 10.1093/jnci/djs188.
21.21. Neumann HPH, Bausch B, Mcwhinney SR, et al. Germline mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459-1466. doi: 10.1056/NEJMoa020152.
22.22. Jafri M, Whitworth J, Rattenberry E, et al. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma. Clin Endocrinol (Oxf). 2013;78(6):898-906. doi: 10.1111/cen.12074.
23.23. Brito JP, Asi N, Bancos I, et al. Testing for germline mutations in sporadic pheochromocytoma/paraganglioma: A systematic review. Clin Endocrinol (Oxf). 2015;82(3):338-345. doi: 10.1111/cen.12530.
24.24. Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: Lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med. 2009; 266(1):19-42. doi: 10.1111/j.1365-2796.2009.02111.x.
25.25. Cascon A, Inglada-Perez L, Comino-Mendez I, et al. Genetics of pheochromocytoma and paraganglioma in spanish pediatric patients. Endocr Relat Cancer. 2013;20(3):L1-L6. doi: 10.1530/erc-12-0339.
26.26. Eisenhofer G, Lenders JWM, Timmers H, et al. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem. 2011;57(3):411-420. doi: 10.1373/clinchem.2010.153320.
27.27. Burnichon N, Cascon A, Schiavi F, et al. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res. 2012;18(10):2828-2837. doi: 10.1158/1078-0432.ccr-12-0160.
28.28. Houdayer C, Caux-Moncoutier V, Krieger S, et al. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on brca1 and brca2 variants. Hum Mutat. 2012;33(8):1228-1238. doi: 10.1002/humu.22101.
29.29. Shao Y, Chen R, Shen Z-J, et al. Preoperative alpha blockade for normotensive pheochromocytoma. J Hypertens. 2011; 29(12):2429-2432. doi: 10.1097/HJH.0b013e32834d24d9.
30.30. Jankovic RJ, Konstantinovic SM, Milic DJ, et al. Can a patient be successfully prepared for pheochromocytoma surgery in three days? A case report. Minerva Anestesiol. 2007; 73:245-248.
31.31. Agarwal G, Sadacharan D, Aggarwal V, et al. Surgical management of organ contained unilateral pheochromocytoma: Comparative outcomes of laparoscopic and conventional open surgical procedures in a large single institution series. Langenbecks Arch Surg. 2011;397(7):1109-1116. doi: 10.1007/s00423-011-0879-3.
32.32. Goers TA, Abdo M, Moley JF, et al. Outcomes of resection of extra adrenal pheochromocytomas/paragangliomas in the laparoscopic era: A comparison with adrenal pheochromocytoma. Surg Endosc. 2012;27(2):428-433. doi: 10.1007/s00464-012-2451-9.
33.33. Alesina PF, Hinrichs J, Meier B, et al. Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas. Langenbecks Arch Surg. 2011;397(2):233-238. doi: 10.1007/s00423-011-0851-2.
34.34. Amar L, Fassnacht M, Gimenez-Roqueplo AP, et al. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma. Horm Metab Res. 2012;44(05):385-389. doi: 10.1055/s-0031-1301339.

Russian Association of Endocrinologists clinical practice guidelines for diagnosis and treatment of pheochromocytoma and paraganglioma

Russian clinical practice guidelines are dedicated to the management of patients with pheochromocytoma and paraganglioma.

Keywords:
pheochromocytoma, paraganglioma, screening, plasma free metanephrines, urinary fractionated metanephrines, liquid chromatography, mass spectrometry, computed tomography, magnetic res-onance imaging, 123I-metaiodobenzylguanidine, 18F-fluorodeoxyglucose, феохромоцитома, параганглинома, скрининг, метанефрины, жидкостная хроматография, масс-спектрометрия, компьютерная томография, магнитно-резонансная